Evidence map›Paper›PMID 26681596›Full record

ReviewNature materials2016

Supramolecular biomaterials.

Matthew J Webber, Eric A Appel, E W Meijer, Robert Langer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 403 papers.

0numbers the graph read from it
0cells of the map it votes in
403citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

403 citing papers in PubMed.

  1. Article
  2. Supramolecular Polymer-Surfactant Co-Assemblies for Multivalent HSV-1 Inhibition.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Review
  5. Methyllithium and Its Oligomers as Lewis Bases for Hydrogen and Halogen Bonding.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  6. Electrochemically Triggered Supramolecular Polymerization Under Kinetic Control.Angewandte Chemie (International ed. in English) · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Construction of ZnGels (Basel, Switzerland) · 2026
    Article
  20. Article

343 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew J WebberDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Eric A AppelDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
E W MeijerInstitute for Complex Molecular Systems, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands.
Robert LangerDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

Funding

Array development of anti-inflammatory peptoid-graft polymers for islet deliveryF32DK101335 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WEBBER, MATTHEW · 2013 to 2015
$159k
NIDDK NIH HHS F32DK101335Wellcome Trust
6 · The paper itself

Abstract

Polymers, ceramics and metals have historically dominated the application of materials in medicine. Yet rationally designed materials that exploit specific, directional, tunable and reversible non-covalent interactions offer unprecedented advantages: they enable modular and generalizable platforms with tunable mechanical, chemical and biological properties. Indeed, the reversible nature of supramolecular interactions gives rise to biomaterials that can sense and respond to physiological cues, or that mimic the structural and functional aspects of biological signalling. In this Review, we discuss the properties of several supramolecular biomaterials, as well as their applications in drug delivery, tissue engineering, regenerative medicine and immunology. We envision that supramolecular biomaterials will contribute to the development of new therapies that combine highly functional materials with unmatched patient- and application-specific tailoring of both material and biological properties.

Indexed as

Allergy and ImmunologyAnimalsBiomimetic MaterialsDrug Delivery SystemsHumansMacromolecular SubstancesRegenerative MedicineTissue EngineeringMacromolecular Substances

Identifiers

PMID26681596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.